These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2842093)

  • 1. Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus.
    Krowka J; Stites D; Mills J; Hollander H; McHugh T; Busch M; Wilhelm L; Blackwood L
    Clin Exp Immunol; 1988 May; 72(2):179-85. PubMed ID: 2842093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.
    Weinhold KJ; Lyerly HK; Stanley SD; Austin AA; Matthews TJ; Bolognesi DP
    J Immunol; 1989 May; 142(9):3091-7. PubMed ID: 2468713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant HIV structural proteins detect specific cellular immunity in vitro in infected individuals.
    Torseth JW; Berman PW; Merigan TC
    AIDS Res Hum Retroviruses; 1988 Feb; 4(1):23-30. PubMed ID: 2835070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
    Weinberg A; Wohl DA; Barrett RJ; van der Horst C
    J Infect Dis; 2001 Sep; 184(6):707-12. PubMed ID: 11517431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection.
    Yu J; Chen H; Horton H; Bansal A; McElrath JM; Reichman R; Goepfert P; Jin X
    J Med Virol; 2006 Sep; 78(9):1147-57. PubMed ID: 16847956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
    HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte proliferative responses to soluble and liposome-conjugated envelope peptides of HIV-1.
    Krowka J; Stites D; Debs R; Larsen C; Fedor J; Brunette E; Düzgünes N
    J Immunol; 1990 Apr; 144(7):2535-40. PubMed ID: 1969450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.
    Komanduri KV; Donahoe SM; Moretto WJ; Schmidt DK; Gillespie G; Ogg GS; Roederer M; Nixon DF; McCune JM
    Virology; 2001 Jan; 279(2):459-70. PubMed ID: 11162802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative T-cell response to HIV envelope glycoprotein in immunized and infected primates and human beings.
    Krohn K; Ranki A; Lusso P; Moss B; Ashorn P; Arthur LO; Putney SD; Gallo RC
    J Med Primatol; 1989; 18(3-4):363-9. PubMed ID: 2547967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
    J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte activation by HIV-1 envelope glycoprotein.
    Kornfeld H; Cruikshank WW; Pyle SW; Berman JS; Center DM
    Nature; 1988 Sep; 335(6189):445-8. PubMed ID: 2843775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals.
    Clerici M; Stocks NI; Zajac RA; Boswell RN; Bernstein DC; Mann DL; Shearer GM; Berzofsky JA
    Nature; 1989 Jun; 339(6223):383-5. PubMed ID: 2524668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1.
    Lusso P; Markham PD; Ranki A; Earl P; Moss B; Dorner F; Gallo RC; Krohn KJ
    J Immunol; 1988 Oct; 141(7):2467-73. PubMed ID: 3262661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
    J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytomegalovirus (CMV)-specific CD8+ T cell responses are reduced in HIV-infected individuals with a history of CMV disease despite CD4+ T cell recovery.
    Singh KP; Howard JL; Wild SP; Jones SL; Hoy J; Lewin SR
    Clin Immunol; 2007 Aug; 124(2):200-6. PubMed ID: 17574925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative responses to human immunodeficiency virus type 1 (HIV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controls.
    Sitz KV; Ratto-Kim S; Hodgkins AS; Robb ML; Birx DL
    J Infect Dis; 1999 Apr; 179(4):817-24. PubMed ID: 10068576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells generated during cytomegalovirus in vitro stimulation of mononuclear cells from HIV-infected individuals on HAART correlate with decreased lymphocyte proliferation.
    Jesser RD; Li S; Weinberg A
    Virology; 2006 Sep; 352(2):408-17. PubMed ID: 16782163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.